Infection of mouse bone marrow-derived dendritic cells with recombinant adenovirus vectors leads to presentation of encoded antigen by both MHC class I and class II molecules-potential benefits in vaccine design

By Herrera O.B.   Brett S.   Lechler R.I.  

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 231-242

Elsevier

Access to resources Recommend Favorite

MHC class I- and class II-restricted processing and presentation of microencapsulated antigens

By Men Y.   Audran R.   Thomasin C.   Eberl G.   Demotz S.   Merkle H.P.   Gander B.   Corradin G.  

Vaccine, Vol. 17, Iss. 9, 1999-03 ,pp. : 1047-1056

Elsevier

Access to resources Recommend Favorite

Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres

By Ying M.   Gander B.   Merkle H.P.   Corradin G.  

Vaccine, Vol. 14, Iss. 15, 1996-10 ,pp. : 1442-1450

Elsevier

Access to resources Recommend Favorite

The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation

By Oh Y.-K.   Harding C.V.   Swanson J.A.  

Vaccine, Vol. 15, Iss. 5, 1997-04 ,pp. : 511-518

Elsevier

Access to resources Recommend Favorite

In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability

By Lipford G.B.   Bauer S.   Wagner H.   Heeg K.  

Vaccine, Vol. 13, Iss. 3, 1995-01 ,pp. : 313-320

Elsevier

Access to resources Recommend Favorite